Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Aytu Bioscience
68,7
%
| 61 | 63,2 % | 74 | 68,7 % | +20,74% |
Aytu Consumer Health
31,3
%
| 36 | 36,8 % | 34 | 31,3 % | -5,48% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
99,6
%
| 95 | 97,9 % | 107 | 99,6 % | +13,01% |
International
0,4
%
| 2 | 2,1 % | 0 | 0,4 % | -76,68% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | 16/04/15 |
Jarrett Disbrow
FOU | Founder | 49 | 16/04/15 |
Mark Oki
DFI | Director of Finance/CFO | 55 | 17/01/22 |
Margaret Cabano
COO | Chief Operating Officer | - | 01/01/05 |
Russell McMahen
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Greg Pyszczymuka
PRN | Corporate Officer/Principal | - | 01/01/22 |
Suzane Kennedy
LAW | General Counsel | - | 01/06/18 |
Ryan J. Selhorn
PRN | Corporate Officer/Principal | 42 | - |
Victoria Cordova
HRO | Human Resources Officer | - | 01/03/23 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Vivian Liu
BRD | Director/Board Member | 62 | 01/07/22 |
Jarrett Disbrow
FOU | Founder | 49 | 16/04/15 |
Joshua Disbrow
CEO | Chief Executive Officer | 49 | 16/04/15 |
John Donofrio
BRD | Director/Board Member | 56 | 12/07/16 |
Carl Dockery
BRD | Director/Board Member | 61 | 13/04/16 |
Abhinav Jain
BRD | Director/Board Member | 33 | 12/06/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 5 972 327 | 5 773 410 ( 96,67 %) | 0 | 96,67 % |
Coordinate società
Aytu Biopharma, Inc.
7900 East Union Avenue Suite 920
80237, Englewood
+720 437 6580
http://www.aytubio.com![Indirizzo Aytu Bioscience Inc](https://cdn.zonebourse.com/static/address/38209285.png)
Settore
Vendite per attività
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
+62,66% | 854 Mrd | |
+40,42% | 636 Mrd | |
-4,37% | 361 Mrd | |
+17,16% | 324 Mrd | |
+9,87% | 301 Mrd | |
+15,66% | 247 Mrd | |
+4,21% | 230 Mrd | |
+17,90% | 228 Mrd | |
+14,86% | 177 Mrd |